Market Overview
The infertility treatment market covers a wide range of medical interventions addressing rising global infertility rates affecting roughly 1 in 6 people of reproductive age. The market encompasses ART equipment, diagnostic devices, sperm separation systems, ovum aspiration pumps, and related consumables used in fertility clinics and hospitals. The broader fertility services market reached approximately $45 billion in 2025, with the devices segment valued at approximately $2.2 billion, representing specialized equipment essential for IVF and other assisted reproduction procedures.
- •The global infertility treatment devices segment was valued at approximately $2.21 billion in 2025
- •The broader fertility services and ART market reached approximately $45 billion in 2025
- •Market growth supported by increasing infertility prevalence and delayed childbearing trends
Growth Drivers
Rising infertility rates globally, affecting an estimated 17.5% of adults, combined with increasing maternal age and lifestyle-related reproductive issues, are primary demand drivers. Growing acceptance of ART procedures, expanded insurance coverage in some regions, and technological advancements in embryo culture and genetic screening are accelerating market expansion. The broader fertility services market is projected to grow at 6-12% CAGR through 2034-2035, with the devices segment expected to reach $3.4-3.9 billion by 2031-2035.
- •Rising maternal age and lifestyle factors driving global infertility rates upward
- •Increased acceptance of ART procedures and expanded insurance coverage in key markets
- •Technological advancements in embryo culture, genetic screening, and minimally invasive procedures
Segmentation and Regional Analysis
The market is segmented by product type including ART equipment, sperm separation devices, ovulation induction devices, and imaging systems. Geographically, North America and Europe dominate due to advanced healthcare infrastructure, higher awareness, and favorable reimbursement policies. Asia-Pacific is emerging as the fastest-growing region, driven by rising infertility rates, improving healthcare access, and increasing medical tourism. The Middle East, Latin America, and Africa represent smaller but growing markets as fertility treatment awareness expands.
- •North America and Europe lead in market share due to advanced infrastructure and favorable policies
- •Asia-Pacific is the fastest-growing region driven by rising infertility and medical tourism
- •Segments include ART equipment, sperm separation devices, ovum aspiration pumps, and diagnostic imaging
Trends and Outlook
What are the recent trends and outlook?
Emerging trends include the integration of artificial intelligence in embryo selection, increased use of time-lapse imaging systems, and growing demand for fertility preservation services. Miniaturization of surgical instruments and non-invasive diagnostic techniques are improving patient outcomes and reducing procedure costs. The market is expected to continue expanding as societal attitudes toward fertility treatment evolve, healthcare access improves in emerging markets, and technological innovations make treatments more effective and accessible.
- •AI-powered embryo selection and time-lapse imaging systems gaining adoption in advanced clinics
- •Growing demand for fertility preservation services among cancer patients and career-focused individuals
- •Miniaturization and non-invasive techniques improving patient outcomes and reducing costs
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.